Open AccessTolvaptan, an FDA-approved drug, inhibits Zika virus infection both in vitro and in vivo
Publication year - 2021
Publication title -
journal of chinese pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.138
H-Index - 12
ISSN - 1003-1057
DOI - 10.5246/jcps.2021.03.017
Subject(s) - zika virus , in vivo , tolvaptan , approved drug , drug , virology , medicine , pharmacology , in vitro , virus , chemistry , biology , heart failure , microbiology and biotechnology , biochemistry